vs
Amentum Holdings, Inc.（AMTM）与爱德华生命科学（EW）财务数据对比。点击上方公司名可切换其他公司
Amentum Holdings, Inc.的季度营收约是爱德华生命科学的2.0倍（$3.2B vs $1.6B），爱德华生命科学净利率更高（23.1% vs 1.4%，领先21.7%），爱德华生命科学同比增速更快（16.7% vs -5.2%），过去两年Amentum Holdings, Inc.的营收复合增速更高（25.6% vs 9.7%）
本公司是总部位于美国达拉斯的跨国技术专业服务企业，面向全球企业、机构及政府部门客户提供工程、技术、建设服务以及科学与专项咨询服务，连续6年蝉联《工程新闻纪录》（ENR）全球顶尖设计企业500强榜首。
爱德华生命科学是总部位于美国加利福尼亚州尔湾的医疗科技企业，专注于人工心脏瓣膜及血流动力学监测领域，其研发的Sapien经导管主动脉心脏瓣膜采用牛组织材质，搭配球囊扩张式钴铬合金支架，可通过导管完成植入。
AMTM vs EW — 直观对比
营收规模更大
AMTM
是对方的2.0倍
$1.6B
营收增速更快
EW
高出21.9%
-5.2%
净利率更高
EW
高出21.7%
1.4%
两年增速更快
AMTM
近两年复合增速
9.7%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $3.2B | $1.6B |
| 净利润 | $44.0M | $380.7M |
| 毛利率 | 10.1% | 78.0% |
| 营业利润率 | 4.3% | 1.8% |
| 净利率 | 1.4% | 23.1% |
| 营收同比 | -5.2% | 16.7% |
| 净利润同比 | 266.7% | 6.8% |
| 每股收益（稀释后） | $0.18 | $0.66 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMTMEW
| Q1 26 | $3.2B | $1.6B | ||
| Q4 25 | $3.9B | $1.6B | ||
| Q3 25 | — | $1.6B | ||
| Q2 25 | $3.6B | $1.5B | ||
| Q1 25 | $3.5B | $1.4B | ||
| Q4 24 | $3.4B | $1.4B | ||
| Q3 24 | $2.2B | $1.4B | ||
| Q2 24 | $2.1B | $1.4B |
净利润AMTMEW
| Q1 26 | $44.0M | $380.7M | ||
| Q4 25 | $40.0M | $91.2M | ||
| Q3 25 | — | $291.1M | ||
| Q2 25 | $10.0M | $333.2M | ||
| Q1 25 | $4.0M | $358.0M | ||
| Q4 24 | $12.0M | $385.6M | ||
| Q3 24 | $26.0M | $3.1B | ||
| Q2 24 | $-26.0M | $366.3M |
毛利率AMTMEW
| Q1 26 | 10.1% | 78.0% | ||
| Q4 25 | 10.6% | 78.1% | ||
| Q3 25 | — | 77.8% | ||
| Q2 25 | 10.3% | 77.5% | ||
| Q1 25 | 10.5% | 78.7% | ||
| Q4 24 | 10.6% | 78.9% | ||
| Q3 24 | 9.0% | 80.6% | ||
| Q2 24 | 9.6% | 79.9% |
营业利润率AMTMEW
| Q1 26 | 4.3% | 1.8% | ||
| Q4 25 | 3.4% | 9.6% | ||
| Q3 25 | — | 19.8% | ||
| Q2 25 | 2.9% | 26.8% | ||
| Q1 25 | 3.2% | 27.9% | ||
| Q4 24 | 3.9% | 22.6% | ||
| Q3 24 | 1.2% | 25.9% | ||
| Q2 24 | 4.2% | 26.8% |
净利率AMTMEW
| Q1 26 | 1.4% | 23.1% | ||
| Q4 25 | 1.0% | 5.8% | ||
| Q3 25 | — | 18.7% | ||
| Q2 25 | 0.3% | 21.7% | ||
| Q1 25 | 0.1% | 25.3% | ||
| Q4 24 | 0.4% | 27.8% | ||
| Q3 24 | 1.2% | 226.7% | ||
| Q2 24 | -1.2% | 26.7% |
每股收益（稀释后）AMTMEW
| Q1 26 | $0.18 | $0.66 | ||
| Q4 25 | $0.16 | $0.16 | ||
| Q3 25 | — | $0.50 | ||
| Q2 25 | $0.04 | $0.56 | ||
| Q1 25 | $0.02 | $0.61 | ||
| Q4 24 | $0.05 | $0.65 | ||
| Q3 24 | $0.31 | $5.13 | ||
| Q2 24 | $-0.29 | $0.61 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $247.0M | — |
| 总债务越低越好 | $3.9B | — |
| 股东权益账面价值 | $4.6B | — |
| 总资产 | $11.2B | — |
| 负债/权益比越低杠杆越低 | 0.86× | — |
8季度趋势，按日历期对齐
现金及短期投资AMTMEW
| Q1 26 | $247.0M | — | ||
| Q4 25 | $437.0M | $4.2B | ||
| Q3 25 | — | $3.8B | ||
| Q2 25 | $738.0M | $4.1B | ||
| Q1 25 | $546.0M | $3.9B | ||
| Q4 24 | $522.0M | $4.0B | ||
| Q3 24 | $452.0M | $4.4B | ||
| Q2 24 | — | $2.0B |
总债务AMTMEW
| Q1 26 | $3.9B | — | ||
| Q4 25 | $3.9B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $4.5B | — | ||
| Q1 25 | $4.7B | — | ||
| Q4 24 | $4.7B | — | ||
| Q3 24 | $4.7B | — | ||
| Q2 24 | — | — |
股东权益AMTMEW
| Q1 26 | $4.6B | — | ||
| Q4 25 | $4.5B | $10.3B | ||
| Q3 25 | — | $10.2B | ||
| Q2 25 | $4.5B | $10.5B | ||
| Q1 25 | $4.4B | $10.1B | ||
| Q4 24 | $4.5B | $10.0B | ||
| Q3 24 | $4.5B | $9.5B | ||
| Q2 24 | $303.0M | $7.4B |
总资产AMTMEW
| Q1 26 | $11.2B | — | ||
| Q4 25 | $11.5B | $13.7B | ||
| Q3 25 | — | $13.3B | ||
| Q2 25 | $11.8B | $13.5B | ||
| Q1 25 | $12.0B | $13.0B | ||
| Q4 24 | $11.9B | $13.1B | ||
| Q3 24 | $12.0B | $13.0B | ||
| Q2 24 | — | $10.1B |
负债/权益比AMTMEW
| Q1 26 | 0.86× | — | ||
| Q4 25 | 0.88× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.01× | — | ||
| Q1 25 | 1.06× | — | ||
| Q4 24 | 1.05× | — | ||
| Q3 24 | 1.05× | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-136.0M | — |
| 自由现金流经营现金流 - 资本支出 | $-142.0M | — |
| 自由现金流率自由现金流/营收 | -4.4% | — |
| 资本支出强度资本支出/营收 | 0.2% | — |
| 现金转化率经营现金流/净利润 | -3.09× | — |
| 过去12个月自由现金流最近4个季度 | $272.0M | — |
8季度趋势，按日历期对齐
经营现金流AMTMEW
| Q1 26 | $-136.0M | — | ||
| Q4 25 | $270.0M | $450.9M | ||
| Q3 25 | — | $573.7M | ||
| Q2 25 | $106.0M | $290.2M | ||
| Q1 25 | $57.0M | $280.4M | ||
| Q4 24 | $110.0M | $-127.5M | ||
| Q3 24 | — | $351.8M | ||
| Q2 24 | — | $371.5M |
自由现金流AMTMEW
| Q1 26 | $-142.0M | — | ||
| Q4 25 | $261.0M | $353.5M | ||
| Q3 25 | — | $516.2M | ||
| Q2 25 | $100.0M | $240.9M | ||
| Q1 25 | $53.0M | $224.4M | ||
| Q4 24 | $102.0M | $-177.3M | ||
| Q3 24 | — | $299.9M | ||
| Q2 24 | — | $286.1M |
自由现金流率AMTMEW
| Q1 26 | -4.4% | — | ||
| Q4 25 | 6.6% | 22.5% | ||
| Q3 25 | — | 33.2% | ||
| Q2 25 | 2.8% | 15.7% | ||
| Q1 25 | 1.5% | 15.9% | ||
| Q4 24 | 3.0% | -12.8% | ||
| Q3 24 | — | 22.1% | ||
| Q2 24 | — | 20.9% |
资本支出强度AMTMEW
| Q1 26 | 0.2% | — | ||
| Q4 25 | 0.2% | 6.2% | ||
| Q3 25 | — | 3.7% | ||
| Q2 25 | 0.2% | 3.2% | ||
| Q1 25 | 0.1% | 4.0% | ||
| Q4 24 | 0.2% | 3.6% | ||
| Q3 24 | — | 3.8% | ||
| Q2 24 | — | 6.2% |
现金转化率AMTMEW
| Q1 26 | -3.09× | — | ||
| Q4 25 | 6.75× | 4.94× | ||
| Q3 25 | — | 1.97× | ||
| Q2 25 | 10.60× | 0.87× | ||
| Q1 25 | 14.25× | 0.78× | ||
| Q4 24 | 9.17× | -0.33× | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 1.01× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMTM
| Global Engineering Solutions Segment | $1.9B | 59% |
| Other U.S.Government Agencies | $400.0M | 12% |
| Fixed Price Contract | $380.0M | 12% |
| Commercial And International | $226.0M | 7% |
| Time And Materials Contract | $171.0M | 5% |
| Sales Channel Through Intermediary | $78.0M | 2% |
| Equity Method Investee | $50.0M | 2% |
EW
暂无分部数据
